That's important, because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. In other words, we need to understand how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error procedure (biotech stocks jeff brown). However now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're designed to do. This was an advancement practically nobody observed. However it's going to have extensive ramifications for curing disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment opportunities in this area, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (melania trump). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back perhaps significantly before going higher - future report. I have actually been covering bitcoin for a long time now. One of the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mainly educating readers. However that's not the big question any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. the legacy report predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so numerous terrific personal companies on the verge of hitting the public markets And I've been working on a brand-new method for you to invest even prior to these business go public.
This opportunity has actually been constructing over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to book your area free of charge.
Emma Walsh here, managing editor of the Journal. Routine Diary readers understand that tech isn't our normal beat (tech predictions). And when it pertains to tech investing, we leave it to the specialists. Thankfully, we have several such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing experts we understand (white house). In truth, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and anticipate what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These patterns are experiencing rapid growth and producing incredible opportunities for investors. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. jeff brown stock market prediction. But regardless of what numerous readers might believe, this is a trend that's simply starting. Despite the fact that the COVID-19 pandemic disrupted supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (toxic tech 5 tech darlings). Losing 2 months of production and sales actually impacts how numerous 5G gadgets are sold in the fiscal year. When you consider all of that, offering 250 million systems is remarkable. More importantly, the hold-ups brought on by the pandemic produced a lots of bottled-up demand. Which demand is now going to be pushed into 2021. In fact, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown biotech picks. Which's not my only 5G prediction When I have actually spoken about 5G in the past, I've described its three different stages.
In Phase 2, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Phase Three, 5G services start to be used (jeff brown prediction for 2021). That's when we begin to see applications working on 5G networks. Think about things like enormous multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage 3 by this summer season. This starts something of a virtuous cycle: Many people don't actually care about the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In reality, 5G is going to open a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment chances moving forward will be huge. Stepping away from 5G, the next crucial innovation I anticipate in 2021 is CRISPR genetic editing. CRISPR means "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it is among the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software application.
The program can crash or not work correctly. CRISPR utilizes a comparable idea but with our genetic code. "Typos" in our genome can lead to disease. CRISPR can correct these "typos." For several years, CRISPR was primarily a niche innovation that wasn't well understood. And throughout that time, there were really only 3 companies operating in this area. But things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR business is going public and providing unbelievable returns. This entire industry is effectively a greenfield chance.
There's room for many business to exist in this space. jeff bezos. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or 3 more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things happening at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software application can precisely anticipate the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is very important due to the fact that the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental process. However now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're created to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but numerous drug treatments produced using this innovation. This was among those breakthroughs that almost nobody observed. But it's going to have extensive ramifications for curing illness. And, obviously, there will be plenty of investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back possibly significantly prior to going greater. I've been covering bitcoin for a long time now. One of the very first research reports I ever released was on bitcoin - tech stocks. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. But at the time of that preliminary recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. last week. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date since February 2021, but we could not individually validate this claim. Provided Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this moment. Brown is best understood for his sage-like capability to pick winning technology stocks. He spent more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an outstanding point of view on the market. He's always on the hunt for new chances, and he shares numerous of his best choices in the Near Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively forecasted a few of the greatest economic occasions of the previous twenty years. Although he does not appear to launch his choices to the public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it ideal each time, however Jeff Brown's accurate predictions have earned him legions of dedicated fans. That states a lot about his ability. The Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research study offers a number of research services with a wide range of specializations - exponential growth.
The business is also associated with Bonner & Partners, another well-respected research study publisher - artificial intelligence. On its website, Brownstone states its objective is to supply retail investors with professional-grade research study: "For too long, the very best investment research has actually not been available to specific financiers. It has been normally reserved for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown. The mission of Brownstone Research study is to make that sort of exclusive research study readily available to any investors aiming to gain an edge in the markets. The objective is basic to provide distinct and rewarding investment research found nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also works as the firm's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After years of consistent success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you know even a little bit about the market, you understand that he has a reputation as a King Midas of sorts. jeff brown biotech stock. Everything he touches turns to gold! Jeff is well aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown thinks S.A.V. last week. could be "the greatest pattern of the 2020s, and he's not alone. Examine out these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying two advanced innovations: expert system and electric cars and trucks. Musk hopes the combination will help him establish the very first fully-autonomous, self-driving automobiles ever. It's nothing short of the automotive market's Holy Grail. As you know, electric cars and self-driving automobile stocks have actually been substantial this year, however the Wall Street device has been big on hype without much tangible outcome. In spite of a drastic increase in competitors over the past few years, Brown still believes Musk has the very best opportunity of putting all of it together.
tech could be the magic string that connects everything together. S.A.V. stands for Shared Autonomous Automobile, and it might be the future of transport. Essentially, this innovation would enable you to lease your vehicle as an autonomous, self-driving taxi when you're not using it. You simply get out of the cars and truck and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the revenues. It sounds insane, however it could be closed than you think.